Key result
Intradermal immunization with EV71 and CA16 antigens significantly increased neutralizing antibody titers and activated specific T cell responses compared to intramuscular immunization, providing 100% protection against viral challenge in neonatal mice.
Why the study?
Intramuscular immunization with inactivated EV71 vaccine elicited effective immunity while inactivated CA16 vaccine did not, prompting evaluation of innate immune responses following intradermal versus intramuscular administration.
Does intradermal immunization with EV71 and/or CA16 antigens improve immune responses and protection compared to intramuscular immunization in mice?
Does intradermal immunization with EV71 and/or CA16 antigens improve immune responses and protection compared to intramuscular immunization in mice?
Intradermal immunization with EV71 and CA16 antigens elicits a stronger coordinated innate and adaptive immune response than intramuscular immunization, offering a promising strategy for HFMD vaccine development.
Answers are grounded in this paper and cite their sources.
Supports intradermal HFMD vaccine testing in humans; leaves open translation, durability, and safety.
Enterovirus type 71 (EV71) and coxsackievirus A 16 (CA16) are the major pathogens of human hand, foot, and mouth disease (HFMD). In our previous study, intramuscular immunization with the inactivated EV71 vaccine elicited effective immunity, while immunization with the inactivated CA16 vaccine did not. In this report, we focused on innate immune responses elicited by inactivated EV71 and CA16 antigens administered intradermally or intramuscularly. The distributions of the EV71 and CA16 antigens administered intradermally or intramuscularly were not obviously different, but the antigens were detected for a shorter period of time when administered intradermally. The expression levels of NF-κB pathway signaling molecules, which were identified as being capable of activating DCs, ILCs, and T cells, were higher in the intradermal group than in the intramuscular group. Antibodies for the EV71 and CA16 antigens colocalized with ILCs and DCs in skin and muscle tissues under fluorescence microscopy. Interestingly, ILC colocalization decreased over time, while DC colocalization increased over time. ELISpot analysis showed that coordination between DCs and ILCs contributed to successful adaptive immunity against vaccine antigens in the skin. EV71 and/or CA16 antigen immunization via the intradermal route was more capable of significantly increasing neutralizing antibody titers and activating specific T cell responses than immunization via the intramuscular route. Furthermore, neonatal mice born to mothers immunized with the EV71 and CA16 antigens were 100% protected against wild-type EV71 or CA16 viral challenge. Together, our results provide new insights into the development of vaccines for HFMD.
No takes yet. Share an insight, caveat, or question.
Fan et al. (2019) studied Enterovirus 71 and Coxsackievirus A16 infection (Hand, foot, and mouth disease) (n=160). Intradermal immunization with inactivated EV71 and/or CA16 antigens vs. Intramuscular immunization was evaluated on Protection against wild-type EV71 or CA16 viral challenge in neonatal mice. Intradermal immunization with EV71 and CA16 antigens significantly increased neutralizing antibody titers and activated specific T cell responses compared to intramuscular immunization, providing 100% protection against viral challenge in neonatal mice.
Synapse has enriched 10 related papers. Consider them for comparative context: